Search
Vera Therapeutics Inc
VERAAdd to Watchlist
41.200USD
-1.460-3.42%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
2.94BMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated:Analyst Rating
Based on
14
analysts
Buy
Current Rating
77.385
Target Price
+81.40%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
562
Total
5
Median
6
Average
Company name
Ratings
Analysts
Vera Therapeutics Inc
VERA
14
CRISPR Therapeutics AG
CRSP
27
Ionis Pharmaceuticals Inc
IONS
27
Beigene Ltd
ONC
27
argenx SE
ARGX
26
IQVIA Holdings Inc
IQV
26
1
2
3
...
113
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Vera Therapeutics Inc's price target?
Analysts forecast that Vera Therapeutics Inc's price target is USD 62.50, with the highest forecast at USD 100.00 and the lowest forecast at USD 23.00.
How have Vera Therapeutics IncVERA's recent earnings per share performed?
The market expectation was USD -1.69, while Vera Therapeutics IncVERA's earnings per share (EPS) for the previous quarter was USD -1.39. EPS for the next quarter is expected at USD -1.62.
What is the analyst rating for Vera Therapeutics Inc?
Based on the ratings of Vera Therapeutics Inc's stock from 14 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.